Short answer: do weight-loss injections fit an overactive thyroid?
An overactive thyroid is not what the boxed warning on Mounjaro and Zepbound is about. That warning concerns medullary thyroid carcinoma and multiple endocrine neoplasia type 2 [7][8]. But an overactive thyroid does make weight and heart rate unstable: the illness itself pulls weight down and speeds the pulse, and these injections can raise heart rate slightly too [7][8][9]. So it may be advisable to get the thyroid controlled first, and then let the treating doctor decide whether and when the injections fit [14]. This article covers three things: what happens to weight and muscle during an overactive thyroid and after treatment, how heart rate is affected from both sides, and how to prepare for a visit that covers the thyroid and weight together. It gives no advice to change any medicine or dose; that stays with the doctor who prescribed it.
Weight while the thyroid is overactive: loss that is not healthy
When the gland makes too much hormone, the body burns more calories than usual, so weight can fall in proportion to how overactive the thyroid is [13]. That loss is not only fat: a 2026 review describes profound weight loss in hyperthyroidism, with falls in fat, muscle and bone mass [2]. Appetite often rises too, so a person can eat more and still lose weight, which is very different from intended weight loss [11][12]. Known symptoms include a fast or irregular heart rate, tremor and unexplained weight loss [10]. An overactive thyroid is about 10 times more common in women than in men and typically starts between ages 20 and 40 [10]. Diagnosis rests on a suppressed thyroid-stimulating hormone with raised free hormones [4]. If weight is falling and you are not trying, that is a reason for a medical assessment, not for weight-loss injections. The causes and tests are covered in our article on hyperthyroidism symptoms and causes.
Read also: Hyperthyroidism symptoms and causes
Why weight comes back, and often overshoots, after treatment
Once hormone levels return to normal, weight lost to the excess hormone comes back [13]. That is the body returning to its baseline, not a failure of willpower. Some people gain even if they did not lose weight at first, because they got used to eating more during the high-appetite phase [13]. A 2025 study followed 110 patients 6 to 36 months after treatment began. Mean weight gain after treatment was 7.4 kg, against 5.3 kg of disease-related weight loss, so weight came back and overshot [1]. More than half (52.7%) gained 10% or more. The markers linked to bigger gains were how much weight was lost during the illness and hormone levels at diagnosis [1]. The latest review points the same way: over time, net weight typically exceeds the lowest weight reached during the overactive phase [2]. If the gland turns underactive after treatment, the picture changes and needs its own follow-up, covered in our article on an underactive thyroid and weight. In short: if you are thinking about injections after treatment, compare your current weight with your pre-illness weight, not with the lowest number you reached.
Read also: An underactive thyroid and weight
Heart rate: the thyroid and the injections both push it up
An overactive thyroid speeds up the heart, and the rhythm may be irregular [10][11]. A thyroid disorder should be suspected when new atrial fibrillation, heart failure or tachycardia-induced cardiomyopathy appears, and treating the thyroid can improve or even reverse those changes [5]. Medicines that calm the pulse control the symptom only; they do not change hormone levels [11][12]. The injections also affect the pulse. The Mounjaro label reports a mean increase of 2 to 4 beats per minute in placebo-controlled trials, against 1 with placebo. A rise of 15 beats or more occurred in 4.3% on placebo and in 10% at the highest dose (15 mg) [7]. The Zepbound label reports a 1 to 3 beat increase [8]. The Wegovy label says to monitor heart rate at regular intervals, reports a mean resting rise of 1 to 4 beats, and a maximum change of 20 beats or more in 26% versus 16% on placebo [9]. The Mounjaro label itself says the clinical relevance of the increase is uncertain [7]. But when the pulse is already high from the thyroid, any extra rise deserves watching. Palpitations or a racing heart at rest should always be reported to the doctor [9].
The boxed warning is not about an overactive thyroid
The boxed warning on Mounjaro and Zepbound says that in rats the drug caused thyroid C-cell tumours, and that it is unknown whether this happens in humans [7][8]. The drug is contraindicated in people with a personal or family history of medullary thyroid carcinoma, or with multiple endocrine neoplasia type 2 [7]. That syndrome is caused by pathogenic variants in the RET gene [15]. So the warning asks about a family history of medullary cancer, not about how active the thyroid is. An overactive thyroid, Graves' disease or toxic nodules are different conditions, identified by hormone tests rather than a tumour test [4]. Equally, worry about cancer is not a reason to skip the family-history question: it is asked once, at assessment. The label advises reporting signs such as a neck mass, trouble swallowing, shortness of breath or persistent hoarseness [7]. For the origin of the rodent findings, the human studies and the calcitonin question, see our dedicated article on Mounjaro, Wegovy and the thyroid; we do not repeat it here.
Why thyroid control comes first
The first reason is that there is no stable weight to measure against while the thyroid is overactive: weight is falling because of the illness and will rebound once treatment works [1][13]. Starting injections in that window would layer drug-driven loss on top of disease-driven loss, which makes the picture harder to read. The second reason is that the pulse is already high [10] and the injections add a little to it [7][9]. The third is that thyroid treatment is chosen by diagnosis, coexisting conditions and patient preference [6], and it takes time: the usual first-line course for Graves' disease is antithyroid drugs for 12 to 18 months [4]. The British Thyroid Foundation says there is no specific reason a person with benign thyroid disease should avoid these injections, but it may be advisable to wait until thyroid hormones are normal. It adds that people on antithyroid drugs may need extra monitoring, and that you should tell your endocrinologist and GP [14]. Timing is a decision between you and the doctor treating your thyroid. At our Maadi branch, internal medicine reviews thyroid results and coordinates with that doctor, because the clinic has no endocrinology department. For who can take the injections in general, see our article on who can take weight-loss injections.
Muscle and body composition: not just the scale
The scale hides the difference between fat and muscle. In the 2026 review, restoring normal thyroid function brings increases in fat, muscle and bone mass [2]. A small study of 57 patients followed for a year with body-composition scanning found fat mass and body-fat percentage rose after treatment at every age, but muscle recovery was weaker over age 40, and lean tissue fell in the group aged 60 and over [3]. The study is small and has a published erratum, so we treat it as a signal, not a rule. In practice: after an overactive thyroid, the body may have lost muscle and be regaining fat. Weight-loss injections lower total weight, so we need to watch that the loss does not come at the expense of muscle. The InBody device available at our clinic gives a picture of fat and muscle that can be compared from visit to visit. We do not offer training or coaching, and bone-density scanning is done outside the clinic if the doctor feels it is needed. What matters is that you are assessed on body composition, not on the scale number alone.
What happens at a weight-and-thyroid visit with us
The visit starts with a full history: thyroid history, who treats it, weight before, during and after the illness, and any family history of medullary thyroid cancer or the endocrine neoplasia syndrome [7][14]. Then we review the latest free thyroid hormone and thyroid-stimulating hormone results, and any antibody test if one was done [4]. Next we measure pulse and blood pressure and ask about palpitations, tremor, sleep and appetite, since these separate a controlled thyroid from one that is still unsettled [10][11]. We also do an InBody body-composition reading. There are two possible outcomes. If the thyroid is still unsettled or the pulse is high, internal medicine coordinates with your treating doctor and follows the thyroid results, and weight is managed with nutrition and follow-up without injections for now. If the thyroid is stable and the history fits, the injection option is discussed within a follow-up plan that includes pulse and body composition [9][14]. In every case, any thyroid or blood pressure medicine stays as it is and is adjusted only by the doctor who prescribed it.
What to bring before the visit
Gather these before you come; they save time and make the decision more precise: • Your latest thyroid tests (thyroid-stimulating hormone and free hormones) with dates [4]. • The name of the doctor following your thyroid and a list of all your medicines with doses; change nothing on that list. • Your pre-illness weight, your lowest weight, and your current weight [1]. • Home pulse readings if you have a device, at rest over several days, with any palpitations or tremor [9][10]. • Family history of thyroid cancer or endocrine tumours [7]. • Any earlier blood tests or heart tracing. And try not to compare yourself with anyone else: injections are not prescribed by weight alone, and follow-up depends on thyroid status, pulse and body composition.
When to book, and where
Book an appointment if: • You have, or had treatment for, an overactive thyroid, your weight is climbing and you want to know whether injections fit [1][13]. • Your weight is falling without a reason and you have palpitations or tremor [10]. • You already use injections and notice a fast pulse at rest [9]. If you have chest pain, fainting or severe, persistent palpitations, go to emergency care straight away, because a rhythm problem with a thyroid disorder can need urgent care [5]. Branches: Maadi (14 El-Mokhtar Street, behind QNB, New Maadi) and Fifth Settlement (CMC Medical Mall, 4th floor, North 90th Street, Wednesdays from 3:30 pm). Weight management and Mounjaro/Wegovy follow-up are available at both. Internal medicine with Dr Mohab Ashraf Fouad is in Maadi only. An InBody device is available for body-composition analysis. For more, watch our clinic video: https://laroseclinics.com/ar/videos/weight-loss-injections-and-thyroid-medication-interactions.
